Quarterly report pursuant to Section 13 or 15(d)

STOCK OPTIONS AND WARRANTS

v3.8.0.1
STOCK OPTIONS AND WARRANTS
3 Months Ended
Mar. 31, 2018
Notes to Financial Statements  
NOTE 13 - STOCK OPTIONS AND WARRANTS

Options

 

Option valuation models require the input of highly subjective assumptions. The fair value of stock-based payment awards was estimated using the Black-Scholes option model with a volatility figure derived from using the Company's historical stock prices. The Company accounts for the expected life of options based on the contractual life of options for non-employees. For employees, the Company accounts for the expected life of options in accordance with the "simplified" method, which is used for "plain-vanilla" options, as defined in the accounting standards codification.

 

The risk-free interest rate was determined from the implied yields of U.S. Treasury zero-coupon bonds with a remaining life consistent with the expected term of the options.

 

The following table summarizes the stock option activity for the three months ended March 31, 2018:

  

    Shares    

Weighted-Average

Exercise Price

   

Weighted-Average

Remaining

Contractual Term

   

Aggregate

Intrinsic

Value

 
Outstanding at December 31, 2017     47,885,000     $ 0.04       7.5     $ 5,927,877  
Grants     -                          
Exercised     -                          
Expired     -               -       -  
Outstanding at March 31, 2018     47,885,000     $ 0.04       7.3     $ 4,351,028  
Exercisable at March 31, 2018     43,760,000     $ 0.04       7.2     $ 3,887,378  

 

The aggregate intrinsic value in the preceding tables represents the total pretax intrinsic value, based on options with an exercise price less than the Company's stock price of $0.1325 as of March 31, 2018, which would have been received by the option holders had those option holders exercised their options as of that date.

 

The following table presents information related to stock options at March 31, 2018:

 

Options Outstanding     Options  
           

Weighted

Average

   

Exercisable

Exercisable

 
Exercise     Number of     Remaining Life     Number of  
Price     Options     In Years     Options  
                     
$ 0.01-0.025       33,035,000       8.2       28,910,000  
  0.0251-0.05       3,500,000       2.3       3,500,000  
  0.051       11,350,000       6.1       11,350,000  
          47,885,000       7.3       43,760,000  

 

The stock-based compensation expense related to option grants was $78,535 and $78,535 during the three months ended March 31, 2018 and 2017, respectively.

 

As of March 31, 2018, stock-based compensation related to options of $52,357 remains unamortized and is expected to be amortized over the weighted average remaining period of 2 months.

 

Warrants

 

The following table summarizes the changes in warrants outstanding and the related prices for the shares of the Company’s common stock:

 

Warrants Outstanding     Warrants Exercisable  
Exercise Prices     Number Outstanding    

Weighted

Average

Remaining

Contractual

Life

(Years)

   

Weighted

Average

Exercise

Price

   

Number

Exercisable

   

Weighted

Average

Remaining

Contractual

Life (Years)

 
                                 
$ 0.25       1,275,000       1.52     $ 0.25       1,275,000       1.52  
                                             

  

The following table summarizes the warrant activity for the two years ended December 31, 2017:

  

   

Number of

Shares

   

Weighted

Average

Exercise

Price Per

Share

 
Outstanding at January 1, 2018     2,430,000     $ 0.91  
Issued     -          
Exercised     -          
Expired     (1,155,000 )     1.00  
Outstanding at March 31, 2018     1,275,000     $ 0.25